Metropolis Healthcare Limited has scheduled a large-format investor and analyst meet for August 27, 2026. The event is set to begin at 4:00 pm IST and will be conducted as a group interaction. The company confirmed that discussions during the session will be based strictly on publicly available information.

The intimation was issued pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company explicitly stated that no unpublished price-sensitive information (UPSI) is intended to be discussed during the interaction.

Meeting Details

The schedule for the engagement is outlined below:

Participation and Logistics

Participants are requested to RSVP through Strategic Growth Advisors Pvt. Ltd. Mr. Sagar Shroff has been designated as the contact point for registration inquiries. The company noted that changes to the schedule may occur due to exigencies on the part of participants, hosts, or the company itself.

The full intimation is available on the company’s website. The notice was signed by Kamlesh Chandrashekhar Kulkarni, Head – Legal & Secretarial.

Metropolis Healthcare Limited concluded its 26th Annual General Meeting (AGM) on August 18, 2026, with shareholders approving key corporate governance resolutions and financial outcomes for the fiscal year ended March 31, 2026. The meeting, conducted via video conferencing in compliance with Ministry of Corporate Affairs circulars, commenced at 10:00 am and concluded at 10:54 am IST.

The primary financial resolution involved the confirmation of dividend payments for FY26. Shareholders approved the payment of a first interim dividend of ₹4.00 and a second interim dividend of ₹1.00 per equity share, bringing the total payout to ₹5.00 per share for the year. This distribution reflects the company's capital return strategy following the adoption of its audited standalone and consolidated financial statements.

Governance and Appointments

The AGM addressed several critical governance matters, including the re-appointment of board members and external auditors. Dr. Aparna Rajadhyaksha was re-appointed as a director liable to retire by rotation. A special resolution was passed to approve the re-appointment of Dr. Sushil Shah as a Non-Executive Non-Independent Director, along with the continuation of his directorship under SEBI Listing Regulations. The remuneration payable to Dr. Shah was also approved via a special resolution.

Auditor Ratifications

Shareholders appointed M/s. Deloitte Haskins & Sells Chartered Accountants LLP as the Statutory Auditors for the company and fixed their remuneration. Additionally, the remuneration for M/s. Joshi Apte & Associates, the Cost Auditors for the financial year 2026-27, was ratified.

Voting Results

The scrutinizer’s report, submitted by AVS & Associates on August 19, 2026, detailed the voting outcomes for the resolutions. The cut-off date for voting eligibility was August 11, 2026. Remote e-voting was conducted from August 14 to August 17, 2026, while electronic voting took place during the AGM.

Overall participation was high, with approximately 87.09% of outstanding shares polled across most resolutions. The promoter group, holding 9,92,11,984 shares, voted in favour of all resolutions without any dissenting votes. Public institutional holders showed strong support, though minor dissent was recorded on specific governance items.

Notably, the re-appointment of Dr. Aparna Rajadhyaksha saw 23,12,499 votes against (1.28%), primarily from public institutional holders. Similarly, the remuneration for Dr. Sushil Shah faced 23,95,937 votes against (1.33%). All other resolutions, including the adoption of financial statements and the dividend payout, received near-unanimous or unanimous support.

Meeting Proceedings

Ms. Ameera Shah, Chairperson & Whole-time Director, presided over the meeting, providing an overview of the company’s performance in FY25-26 and outlining strategic priorities. The quorum was established with 40 shareholders attending through video conferencing.

The e-voting process, administered by National Securities Depository Limited (NSDL), allowed remote voting from August 14 to August 17, 2026. Voting during the AGM remained open for 15 minutes for those who had not cast remote votes. Mr. Vijay Yadav of M/s. AVS & Associates served as the scrutinizer for the e-voting process.

Statutory auditors from BSR & Co. LLP, internal auditors from PricewaterhouseCoopers Services LLP, secretarial auditors from Manish Ghia & Associates, and cost auditors from Joshi Apte & Associates were present to address shareholder queries. The complete voting results and scrutinizer’s report have been published on the BSE, NSE, and NSDL websites.